Kinnate Biopharma, Inc. (KNTE)
KNTE has a market cap or net worth of $555.00 million. The enterprise value is $288.96 million.
The next earnings date is Monday, August 15, 2022, before market open.
|Estimated Earnings Date||Aug 15, 2022|
KNTE has 43.98 million shares outstanding. The number of shares has increased by 0.93% in one year.
|Shares Change (YoY)||+0.93%|
|Shares Change (QoQ)||+0.36%|
|Owned by Insiders (%)||0.25%|
|Owned by Institutions (%)||94.28%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 20.15, with a Debt / Equity ratio of 0.02.
|Debt / Equity||0.02|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -30.10%, which is considered low. The company has a ROIC of -43.40%.
|Return on Equity (ROE)||-30.10%|
|Return on Assets (ROA)||-26.30%|
|Return on Capital (ROIC)||-43.40%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$1.46M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -46.73% in the last 52 weeks.
|52-Week Price Change||-46.73%|
|50-Day Moving Average||9.40|
|200-Day Moving Average||10.87|
|Average Volume (30 Days)||185,800|
Short Selling Information
The latest short interest is 2.74 million, so 6.23% of the outstanding shares have been sold short.
|Short % of Shares Out||6.23%|
|Short % of Float||17.43%|
|Short Ratio (days to cover)||14.50|
|Earnings Per Share (EPS)||-$2.27|
The company has $270.63 million in cash and $4.60 million in debt, giving a net cash position of $266.04 million or $6.05 per share.
|Cash & Cash Equivalents||270.63M|
|Net Cash Per Share||$6.05|
|Book Value Per Share||6.73|
In the last 12 months, operating cash flow was -$78.71 million and capital expenditures -$2.78 million, giving a free cash flow of -$81.49 million.
|Operating Cash Flow||-78.71M|
|Free Cash Flow||-81.49M|
|FCF Per Share||n/a|
Dividends & Yields
KNTE does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for KNTE is $35.02, which is 177.50% higher than the current price. The consensus rating is "Buy".
|Price Target Difference||177.50%|
This stock does not have any record of stock splits.
|Last Split Date||n/a|